Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fludilat

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1979
1979
Abstract The fine details of the in vivo technique for producing thrombus formation in microcirculation by HeNe laser are… Expand
1978
1978
Increased blood and plasma viscosity was found in patients with chronic arterial occlusion in comparison with healthy probands… Expand
1977
1977
1-Benzyl-1-(3-dimethylaminopropoxy)cycloheptane (bencyclane-hydrogen-fumarate; Fludilat) in a concentration of 10-2 M effects an… Expand
1977
1977
The effect of the following vasoactive substances, which are used in the treatment of peripheral arterial occlusive diseases, was… Expand
1976
1976
In 50 patients suffering from local cerebral circulation disturbances the effects of bencyclan--administered intravenously in a… Expand
1976
1976
  • P. Bock
  • International journal of clinical pharmacology…
  • 1976
  • Corpus ID: 33584878
The quantitative determination of bencyclane from the biological material was carried out with the aid of a combined… Expand
1976
1976
The action of the drug on the electrocardiograph and clinical investigations were carried out on 55 patients treated with… Expand
1975
1975
Bencyclan (Fludilat), used therapeutically as a vasodilator drug, exerts a distinct negative inotropic and chronotropic action on… Expand
1975
1975
Bencyclane (N-[3-(1-benzyl-cycloheptyloxy)-propyl]-N,N-dimethyl-amine-hydrogenfumarate, Fludilat), inhibits phosphodiesterase(PDE… Expand
1975
1975
The platelet aggregation inhibiting effect of N-[3-(1-benzyl-cycloheptyloxy)-propyl]-N,N-dimethyl-amine (bencyclan, Fludilat) was… Expand